ClinicalTrials.govpublic full text
A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects
hiv infections, vaccines, synthetic, hiv-1, hiv envelope protein gp120, aids vaccines, hiv seronegativity, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855639
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.